Occudo Quantitative Strategies’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-9,580
Closed -$299K 1018
2023
Q4
$299K Buy
+9,580
New +$344K 0.04% 538
2023
Q3
Sell
-23,031
Closed -$1.21M 1292
2023
Q2
$1.21M Buy
+23,031
New +$1.4M 0.13% 266
2022
Q1
Sell
-5,109
Closed -$466K 1314
2021
Q4
$466K Buy
5,109
+847
+20% +$90.9K 0.04% 637
2021
Q3
$548K Buy
+4,262
New +$596K 0.07% 503

Other funds holding STAA

Occudo Quantitative Strategies's STAA Position: Q1 2024 in Review

Occudo Quantitative Strategies sold out of STAAR Surgical (STAA) in Q1 2024, closing a stake of 9,580 shares — an estimated $299K sold.

Occudo Quantitative Strategies first reported a position in STAA in Q3 2021 and held it in 4 quarters. The position peaked at $1.21M in Q2 2023. 198 funds tracked by Wall St. Rank hold STAA as of Q1 2024.

  • Occudo Quantitative Strategies reported no remaining STAAR Surgical position as of Q1 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 9,580 STAAR Surgical shares in Q1 2024, an estimated $299K.
  • Occudo Quantitative Strategies first reported a position in STAAR Surgical in Q3 2021 and held it in 4 quarters.
  • Occudo Quantitative Strategies's STAAR Surgical position peaked at $1.21M in Q2 2023.
  • 198 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2024, filed 15 May 2024.